NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased The Medicines Company (the “Company”) (NASDAQ: MDCO) stock prior to November 24, 2019.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of The Medicines Company to Novartis AG (“Novartis”) (NYSE: NVS). Under the terms of the transaction, Novartis will acquire The Medicines Company for $85 per share in an all-cash transaction. To learn more about the action and your rights, go to:

https://www.zlk.com/mna/the-medicines-company

 or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The investigation of The Medicines Company merger concerns whether the Board of The Medicines Company breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether Novartis is underpaying for The Medicines Company shares, thus unlawfully harming The Medicines Company shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com